SPRUCE BIOSCIENCES, INC.

For the period ended Mar 31, 2025. Filed May 6, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 6, 2025

SPRB$46.55+9.0%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Balance Sheets

(in thousands, except share and per share amounts)

	March 31,	December 31,
	2025	2024
ASSETS
Current assets:
Cash and cash equivalents	$25,615	$38,753
Prepaid expenses	2,899	3,177
Other current assets	2,062	2,276
Total current assets	30,576	44,206
Right-of-use assets	869	934
Other assets	204	69
Total assets	$31,649	$45,209
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$1,879	$1,295
Accrued expenses and other current liabilities	12,442	12,329
Term loan, current portion	1,345	1,622
Total current liabilities	15,666	15,246
Lease liabilities, net of current portion	659	736
Term loan, net of current portion	—	124
Other liabilities	—	282
Total liabilities	16,325	16,388
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of March 31, 2025 and December 31, 2024	—	—
Common stock, $0.0001 par value; 200,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 42,231,285 shares issued and outstanding as of March 31, 2025 and December 31, 2024	4	4
Additional paid-in capital	279,629	279,085
Accumulated deficit	(264,309)	(250,268)
Total stockholders’ equity	15,324	28,821
Total liabilities and stockholders’ equity	$31,649	$45,209

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.